Lumida
/EVCM
⌘K
EverCommerce Inc

EverCommerce Inc

EVCM
$12.04USD+1.52%+0.18 today

MARKET CAP

2.1B

P/E (TTM)

15.0x

FWD P/E

15.8x

DAY RANGE

$11 – $12

52W RANGE

$8
$14

AI Summary

Stalk
StalkMedium

The asset remains in a Stage 2 advancing phase following a clear momentum breakout that reaffirms the medium- and long-term uptrends. However, price is extended well above rising EMAs and major moving averages, with extreme overbought readings on RSI and Options Score, indicating near-term exhaustion. Execution should be deferred until a pullback into rising EMAs or the prior breakout zone provides a clearer entry opportunity.

  • Q1 revenue rose 3.6% YoY to $147.5M, topping guidance
  • Investing in AI OS with new AI-powered Scribe features
  • Significant insider share sales by president and other execs
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

EverCommerce Inc. (NASDAQ: EVCM) is a leading service commerce platform that provides technology solutions to small and medium-sized businesses (SMBs) across a diverse array of sectors, primarily focused on healthcare (EverHealth), wellness (EverWell), and professional services (EverPro). By offering integrated software and payment solutions, the company aims to enhance operational efficiencies and customer experiences, positioning itself favorably in the growing software-as-a-service (SaaS) landscape, particularly in the context of rising demand for AI-driven technologies.

Bull says

  • Q1 revenue rose 3.6% YoY to $147.5M, topping guidance
  • Investing in AI OS with new AI-powered Scribe features
  • 32% surge in multi-solution users driving higher retention and ARPU
  • Repurchased 1.3M shares for $13.9M amid 27.6% adj. EBITDA margin
  • Q2 guidance of $150.5–153.5M underscores continued growth
  • Book-to-Price at 1.56 suggests shares may be undervalued

Bear says

  • Significant insider share sales by president and other execs
  • FCF down to $24.6M from $30.7M amid margin headwinds
  • Stock momentum weak and volatility remains elevated
  • Heavy reliance on payment solutions poses adoption risk
  • Low institutional ownership raises liquidity concerns
  • Modest 3.6% Q1 revenue growth keeps analysts on Hold

Investment themes with EVCM

Software +1.28%

Cloud-based digital tools powering business productivity and innovation

PLTR · IBM · CRM
Others +0.32%

Miscellaneous or uncategorized companies

ATAI · SVIX · SVXY

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-07-2026bullish

Transcript signals

Bull points

  • EverHealth AI scribe integrated into Dr. Crono is changing dynamics for orthopedic surgeons, enabling clinical notes that previously took hours to now be completed in just 10 minutes, capturing complex terminology accurately and filtering out non-clinical conversations.
  • This physician estimates savings of more than one hour per day with the added efficiency, leading to a meaningful improvement in his quality of life, as he is now able to finish his day on time and spend more time with family.
  • they centralized their operations and reduced time to get a technician on-site from days down to just four to six hours, driving about a 60% efficiency gain in job management.

Bear points

  • adjusted operating expenses were slightly higher year-over-year as a percentage of revenue, increasing from 46.5% to 50.3%, representing targeted growth investments across sales and marketing and product development, including the post-acquisition Zyra Talk costs.
  • The slight reduction reported NRR was impacted by declining third-party partner revenue within our legacy payments business.
  • The slight reduction reported NRR was impacted by declining third-party partner revenue within our legacy payments business.
Read full transcript analysis ›